I think we must be heading for another trial - bigger and better than BETonMACE to answer all the questions. This is likely to be what the FDA wants. Only a BP could fund such a study, and it would have to be one with an existing portfolio in diabetes, CKD, and CVD. My guess is an announcement is round the corner. all imo